Ellipsometry systems for imaging binding events between analytes in a sample and an array of ligands in an evanescent field generated by a beam of light reflected from the plane of the ligands is adapted to a multiwell plate structure in common use. In one example, a film of prism arrays is affixed to the underside of the plate with each prism array located in registry with a well and ligand arrays being immobilized on the (planar) bottom surface of the wells. The prism array may be formed in a film and juxtaposed with the bottom surface of the plate or a prism array can be made integral with the plate bottom of a multiwell plate.
|
1. An apparatus, comprising:
a plate having therein a plurality of wells, each of the wells having a planar bottom surface for receiving a sample for analysis, wherein the plate has a transparent planar underside; and
an array of prisms affixed to the underside, a plurality of prisms of the array being in registry with a corresponding one of the plurality of wells.
14. A system, comprising:
a plate having therein a plurality of wells, each of the wells having a planar bottom surface including an array of immobilized ligands to receive a sample for analysis,
wherein the plate has a transparent planar underside, and an array of prisms affixed to the underside, a plurality of prisms of the array being in registry with a corresponding one of the plurality of wells and with an associated array of immobilized ligands; and
a source of a beam of light configured to direct the beam to a selected area of the array of immobilized ligands in a manner to achieve total internal reflection and to generate an evanescent field in the plane of the associated array of immobilized ligands.
20. A method of detecting binding events at an array of ligands immobilized on planar bottom surfaces of wells of a multiwell plate, the method comprising:
transmitting a beam of polarized light to a prism film affixed to an underside surface of the plate, the prism film including a plurality of prisms in registry with a corresponding one of the wells, the prism film being of a material and geometry to permit the beam of polarized light incident thereto to be totally internally reflected in a manner to generate an evanescent field in a plane of the array of ligands at which the beam is directed; and
obtaining an image of intensity variations in the reflected beam to detect binding events at said array of ligands.
2. The apparatus as in
3. The apparatus as in
4. The apparatus as in
5. The apparatus of
6. The apparatus of
wherein P is a pitch of the plurality of prisms, θ is an angle of incidence of a beam of light totally internally reflected from the planar bottom surface of the corresponding one of the plurality of wells, and n is an integer.
7. The apparatus as in
8. The apparatus as in
9. The apparatus as in
10. The apparatus as in
11. The apparatus as in
wherein P is a pitch of the plurality of prisms and θ is an angle of incidence of a beam of light totally internally reflected from the planar bottom surface of the corresponding one of the plurality of wells.
13. The apparatus of
wherein P is a pitch of the plurality of prisms and θ is an angle of incidence of a beam of light totally internally reflected from the planar bottom surface of the corresponding one of the plurality of wells.
15. The system as in
16. The system as in
17. The system as in
18. The system as in
|
This application is related to pending U.S. application Ser. No. 11/677,674, filed Feb. 22, 2007, pending U.S. application Ser. No. 11/748,023, filed May 14, 2007, pending U.S. application Ser. No. 11/696,369, filed Apr. 4, 2007, and pending U.S. application Ser. No. 11/752,056, filed May 22, 2007, the contents of which are incorporated by reference herein for all purposes.
This invention relates to an apparatus for characterizing molecular binding events when performing ligand binding assays and more particularly to such systems employing ligand spots or microarrays in a multiwell, integrated optics format.
U.S. Pat. No. 6,594,011 issued Jul. 15, 2003, the entirety of which is incorporated by reference herein for all purposes, discloses an imaging apparatus and method for real time imaging ellipsometry for high throughput sensing of binding events useful in molecular interaction analysis including biotech applications. The apparatus disclosed employs the immobilization of an array of binding or capture molecules (“ligands”) on a planar surface of a transparent substrate and the use of a beam of polarized light directed at the underside of the surface in a manner to achieve total internal reflection (TIR) and generate an evanescent field in the plane of the ligands. The ligands are exposed to a biological sample and analytes in the biological sample bind to different patterns of the immobilized ligands in a manner to change the polarization at locations in the array at which binding occurs. An image of the array is compared with a stored image of the initial light polarization shifts to determine the location and magnitude of binding events within the array, thus identifying and quantitating the analytes present in the biological sample.
The apparatus for implementing the foregoing technique employs a prism or gratings to achieve the requisite TIR generated evanescent field, the prism being the most practical implementation for imaging applications.
TIR imaging ellipsometry works well for fields of view up to 1-2 cm2, which permits real time imaging of tens of thousands of binding events simultaneously. However, there is a need to be able to image or scan areas which are much larger, such as 128 mm×86 mm (e.g., the area of both 384 well and 96 well plates) to permit lower costs per test and for multiple tests per patient for large numbers of patients simultaneously, which is increasingly a requirement for clinical diagnostics and personalized medicine. Simply scaling up the prism geometry so that the field of view covers an entire 1536 well, 384 well or 96 well plate has the following practical and technical drawbacks. In addition to the high expense of large optics, image quality becomes more challenging to maintain as the field of view is increased. Spherical aberration effects, optical path-length and depth of field issues demand much more space in order to keep the quantitative imaging errors low. Additionally, because the optics are too expensive and bulky to be part of the disposable plate, the optical coupling to the disposable plate is done by the user and in many applications, this is not practical, especially when high throughput is required. Obviating the need for a prism simplifies both the instrument and interface between the instrument and disposable multiwell plate.
The present invention provides an advantageous apparatus, system, and method for performing ligand binding assays using microarrays in a multiwell plate format. The invention is based on the realization that the aforementioned imaging ellipsometer system could be adapted to the familiar multiwell plate by positioning an array of mini-prisms on the underside of a multiwell plate, to eliminate the need for a user to manually or otherwise optically couple prisms to the bottom of the disposable plate as has been previously required. The present invention provides for a completely integrated, low cost disposable plate where ligand arrays can be printed on the inside bottom of the individual wells of a multiwell plate, which then allows a beam of polarized light to be directed through a prism film attached to the external plate bottom to achieve TIR and an evanescent field in the plane of the ligands. In one embodiment, each prism of a prism array is in registry with a well. For a standard ninety-six well plate, for example, an array of ninety-six prisms are attached to the plate underside with each prism in registry with a corresponding well.
In one embodiment, in accordance with this invention, a single continuous sheet of prisms is located on the underside of a glass bottom microwell plate where individual prisms are parallel to either rows or columns of wells in the plate, and the bottom surface of each well illustratively is planar and an array of ligands is immobilized on that planar inside bottom surface. Light, directed into a mini-prism array corresponding to a selected well or wells in a manner to achieve total internal reflection, generates an evanescent field in the plane of the array of ligands there and captures in the reflected light, an image of binding events between analytes in a sample in the well and the ligands immobilized on the well bottom surface. The image so captured is compared to an initialized image in a manner explained in the above-identified patent application and which is now well understood in the art.
The scope of the invention is defined by the claims, which are incorporated into this section by reference. A more complete understanding of embodiments of the present invention will be afforded to those skilled in the art, as well as a realization of additional advantages thereof, by a consideration of the following detailed description of one or more embodiments. Reference will be made to the appended sheets of drawings that will first be described briefly.
Embodiments of the present invention and their advantages are best understood by referring to the detailed description that follows. It should be appreciated that like reference numerals are used to identify like elements illustrated in one or more of the figures. It should also be appreciated that the figures may not be necessarily drawn to scale.
Prior to describing embodiments of the present invention in greater detail, the following definition is provided for use throughout the present document.
Convex Figure: A figure is convex if every line segment drawn between any two points inside the figure lies entirely inside the figure. This definition is more general than the definition of a polygon since the edges of the figure can be curved.
The recognition that an individual well bottom surface of a familiar multiwell plate can be adapted for the placement of an immobilized ligands array pattern which could be imaged through a prism array on the underside of the plate in registry with the well is considered a significant contribution in the art. Such an adaptation also allows for an array of truncated mini prisms, each prism of the array located to achieve a miniaturized system of the type shown in
Optimized low birefringent plastic prism arrays are easily and inexpensively produced and thus not only avoids the high cost of an individual glass prism per well, with the arduous application of index matching liquid, but also avoids the problem of unwanted birefringent problems normally encountered if the prism is formed of most injection molded plastics.
Referring now to
In order for neighboring prisms not to “shadow” or block the light source from entering the planar prism faces, there are certain constraints on the geometry of the prism film structure. Examples of the height “H” and pitch “P” of the prisms are shown in
where P is the prism pitch and θ is the AOI of the light beam.
The distance “X” between adjacent prisms is determined by
This means that the glass thickness and prism film thickness should be chosen to meet this requirement in the general case. For the example here, the thickness difference between the maximum and minimum amount of light throughput is only ˜30 μm. Besides the difficulty in achieving these low tolerances when the glass substrate may be as thick as 1 mm, equation 3 does not take into account light diffraction which will decrease the thickness dependence with smaller and smaller prisms.
The prism pitch P is scalable from at least the micron scale to the centimeter scale where critical alignment requirements of the prisms only occur when the prism pitch approaches the spot to spot spacing in the ligand array (typically on the order of 0.1 mm). As the individual prisms become much smaller, alignment becomes less critical with the tradeoff that diffraction effects become more critical.
Referring to
The prism arrays may be embossed, stamped or rolled from a continuous layer of UV-curable monomer or polymer of which Cyclic Olefin Copolymer (COC), Cyclic Olefin Polymer (COP), polyester, acrylic, polycarbonate, polystyrene, polypropylene or optical quality resins are examples. In such a case, the resulting prism film can have a thickness in the range of about 0.075-0.75 mm in one example. The prism array is bonded to the plate underside with an index matching adhesive so that the prisms act to couple the incident light of the imaging system into the transparent material (glass or plastic) which forms the bottom of the wells so that total internal reflection can occur at the plane where ligand arrays reside. The prism array is fabricated from high optical quality material and is processed in a manner to have a total birefringence of less than 1×10−5.
The prism array may also be created by rolling a plastic in liquid form over a negative mold. This prism film could be a dielectric with excellent optical properties which hardens by UV-curing or other catalytic curing process. In one particular embodiment, the prism film itself can be made from a metal silicon or ceramic master mold or pattern onto which a UV-curing low-birefringence material is poured or rolled and cured. Prism arrays can be hot embossed in a suitable, transparent layer of, for example, plastic polymer which has an index of refraction between 1.46 and 1.59 selected to match the index of the ligand array support on which the wells are formed.
In a specific embodiment of this invention, a UV-curable, low birefringence polymer was poured into a metal master. A nominally planar sheet 100 of carrier material with selected optical and mechanical properties (
Embodiments using metal and silicon master patterns have also been tested using UV curable, low-birefringence polymer for the prism film with prism film thicknesses of between 40 and 1000 microns. Carrier sheets (e.g., sheet 100 of
While the invention is described in terms of specific embodiments, other embodiments could readily be adapted by one skilled in the art. For example, prism array 56 is not limited to being formed of a carrier sheet 100 bonded to a prism film 101 and may instead be formed without a carrier sheet, which is optional. Furthermore, prism array 56 is not necessarily bonded underneath a substrate 102 but instead may bond directly to a top member 55 to form a multiwell plate, and ligands may be directly placed on a top surface of the prism array.
In accordance with another embodiment of the present invention,
The foregoing Detailed Description is presented for purposes of illustration and disclosure in accordance with the requirements of the law. It is not intended to be exhaustive nor to limit the invention to the precise form(s) described, but only to enable others skilled in the art to understand how the invention may be suited for a particular use or implementation. The possibility of modifications and variations will be apparent to practitioners skilled in the art. No limitation is intended by the description of exemplary embodiments which may have included tolerances, feature dimensions, specific operating conditions, engineering specifications, or the like, and which may vary between implementations or with changes to the state of the art, and no limitation should be implied therefrom. This disclosure has been made with respect to the current state of the art, but also contemplates advancements and that adaptations in the future may take into consideration those advancements, namely in accordance with the then current state of the art. It is intended that the scope of the invention be defined by the claims as written and equivalents as applicable. Reference to a claim element in the singular is not intended to mean “one and only one” unless explicitly so stated. Moreover, no element, component, nor method or process step in this disclosure is intended to be dedicated to the public regardless of whether the element, component, or step is explicitly recited in the Claims. No claim element herein is to be construed under the provisions of 35 USC Sec. 112, sixth paragraph, unless the element is expressly recited using the phrase “means for . . . ” and no method or process step herein is to be construed under those provisions unless the step, or steps, are expressly recited using the phrase “step(s) for . . . ”
Patent | Priority | Assignee | Title |
10314549, | Jul 16 2013 | ALACRITY PATIENT SERVICES, INC | Method and apparatus for monitoring development of medication induced febrile neutropenia |
10451630, | Jun 30 2014 | QUANTA THERAPEUTICS, INC | Systems and methods for high throughput analysis of conformation in biological entities |
10672502, | Apr 02 2015 | BLUELIGHT THERAPEUTICS, INC | Methods for determining protein structure using a surface-selective nonlinear optical technique |
10768174, | Dec 23 2014 | QUANTA THERAPEUTICS, INC | Attachment of proteins to interfaces for use in nonlinear optical detection |
11045149, | Jul 16 2014 | ALACRITY PATIENT SERVICES, INC. | Method and apparatus for monitoring development of medication induced febrile neutropenia |
9182406, | Aug 04 2008 | BLUELIGHT THERAPEUTICS, INC | Nonlinear optical detection of molecules comprising an unnatural amino acid possessing a hyperpolarizability |
9383361, | Apr 25 2012 | QUANTA THERAPEUTICS, INC | Methods for detecting allosteric modulators of protein |
9395358, | Feb 05 2012 | QUANTA THERAPEUTICS, INC | Methods for detecting allosteric modulators of protein |
9428789, | Mar 21 2011 | BLUELIGHT THERAPEUTICS, INC | Classification of kinase inhibitors using nonlinear optical techniques |
9759663, | Nov 23 2009 | 3M Innovative Properties Company | Microwell array articles and methods of use |
9880102, | Nov 23 2009 | 3M Innovative Properties Company | Microwell array articles and methods of use |
9880172, | Aug 04 2008 | BLUELIGHT THERAPEUTICS, INC | Nonlinear optical detection of molecules comprising an unnatural amino acid possessing a hyperpolarizability |
9989534, | Jun 30 2014 | QUANTA THERAPEUTICS, INC | Systems and methods for high throughput analysis of conformation in biological entities |
Patent | Priority | Assignee | Title |
1637141, | |||
3858616, | |||
4146365, | Nov 07 1977 | Litton Bionetics, Inc. | Affinity detection apparatus |
4238565, | Jun 22 1978 | Miles Laboratories, Inc. | Specific binding assay with a prosthetic group as a label component |
4256834, | Apr 09 1979 | Dade Behring Marburg GmbH | Fluorescent scavenger particle immunoassay |
4508832, | Jun 22 1981 | Prutec Limited | Ellipsometrically measuring rate of optical change in immunoassay |
5164589, | Nov 10 1988 | GE Healthcare Bio-Sciences AB | Reusable optical interface for non-permanent passive light coupling |
5225164, | Sep 30 1991 | Microplate laboratory tray with rectilinear wells | |
5229833, | Sep 26 1990 | MARCONI UK INTELLECTUAL PROPERTY LTD | Optical sensor |
5234769, | Apr 16 1992 | PNC BANK, NATIONAL ASSOCIATION, AS AGENT | Wear resistant transparent dielectric coatings |
5255075, | Mar 22 1991 | GEC-Marconi Limited | Optical sensor |
5313264, | Nov 10 1988 | GE Healthcare Bio-Sciences AB | Optical biosensor system |
5341215, | Jun 08 1991 | Koninklijke Philips Electronics N V | Method and apparatus for detecting the presence and/or concentration of biomolecules |
5437840, | Apr 15 1994 | Agilent Technologies Inc | Apparatus for intracavity sensing of macroscopic properties of chemicals |
5446534, | Mar 05 1993 | OPTICAL SOLUTIONS, INC | Broad band waveguide spectrometer |
5483346, | Apr 11 1994 | CIPHERGEN RESEARCH | Polarization based optical sensor utilizing total internal reflection |
5485277, | Jul 26 1994 | Physical Optics Corporation | Surface plasmon resonance sensor and methods for the utilization thereof |
5491097, | Jun 15 1989 | Biocircuits Corporation | Analyte detection with multilayered bioelectronic conductivity sensors |
5491556, | Jan 11 1992 | Fisons, plc | Analytical device with variable angle of incidence |
5573956, | Aug 20 1991 | Pharmacia Biosensor AB | Assay method based upon refractive index changes at a solid optical surface |
5593130, | Jun 09 1993 | GE Healthcare Bio-Sciences AB | Valve, especially for fluid handling bodies with microflowchannels |
5633724, | Aug 29 1995 | Agilent Technologies Inc | Evanescent scanning of biochemical array |
5641640, | Jun 29 1992 | Biacore AB | Method of assaying for an analyte using surface plasmon resonance |
5738825, | Jul 20 1993 | Unaxis Balzers Aktiengesellschaft | Optical biosensor matrix |
5753518, | May 24 1993 | GE Healthcare Bio-Sciences AB | Method of determining affinity and kinetic properties |
5796858, | May 10 1996 | HOLOSENSORS LLC | Fingerprint sensing system using a sheet prism |
5813439, | Jun 29 1990 | Coflexip | Flexible tubular pipe comprising an interlocked armoring web and process for producing it |
5856873, | Apr 30 1996 | FUJIFILM Corporation | Ellipso sensor using a prism |
5922594, | Sep 26 1994 | GE Healthcare Bio-Sciences AB | Method of producing bilayer lipid membranes |
5922604, | Jun 05 1997 | Gene Tec Corporation | Thin reaction chambers for containing and handling liquid microvolumes |
5955729, | Sep 08 1995 | GE Healthcare Bio-Sciences AB | Surface plasmon resonance-mass spectrometry |
5965456, | Jun 11 1992 | GE Healthcare Bio-Sciences AB | Analyte detection |
5972612, | Jul 14 1995 | GE Healthcare Bio-Sciences AB | Surface-sensitive detection of hybridization at equilibrium |
6008010, | Nov 01 1996 | University of Pittsburgh | Method and apparatus for holding cells |
6008893, | Mar 22 1999 | GE Healthcare Bio-Sciences AB | Reversible-flow conduit system |
6026053, | May 21 1999 | The United States of America as represented by the Director of the; NATURAL SECURITY AGENCY, GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY DIRECTOR, THE | Photorefractive read-only optical memory apparatus using phase, frequency, and angular modulation |
6045996, | Oct 26 1993 | Affymetrix, Inc | Hybridization assays on oligonucleotide arrays |
6065501, | Jun 30 1989 | Institute Francais du Petrole | Flexible tube having at least one elongated reinforcing element with a T-shaped profile |
6127183, | Sep 01 1995 | GE Healthcare Bio-Sciences AB | Monitoring of refractive index of optical sensor for determination of surface structure changes |
6140044, | Jun 08 1994 | AFFYMETRIX, INC , A DELAWARE CORPORATION | Method and apparatus for packaging a probe array |
6143513, | Jun 23 1999 | GE Healthcare Bio-Sciences AB | Method and kit for detecting betalactam-containing compounds |
6143574, | Nov 14 1995 | GE Healthcare Bio-Sciences AB | Method of determining affinity or kinetic properties in solution |
6197595, | Jun 29 1995 | Affymetrix, Inc. | Integrated nucleic acid diagnostic device |
6200814, | Jan 20 1998 | GE Healthcare Bio-Sciences AB | Method and device for laminar flow on a sensing surface |
6207381, | Oct 02 1998 | GE Healthcare Bio-Sciences AB | Method for nucleic acid analysis |
6253793, | Aug 10 1998 | Corlexip | Flexible pipe with i-shaped wire winding |
6277330, | Sep 30 1996 | O S P INC | Optical sensor for detecting chemical substances dissolved or dispersed in water |
6289286, | May 29 1998 | GE Healthcare Bio-Sciences AB | Surface regeneration of biosensors and characterization of biomolecules associated therewith |
6354333, | Aug 10 1998 | Coflexip | Resistant flexible pipe comprising sealing sleeve with limited creep |
6355429, | Feb 26 1985 | THERMO BIOSTAR INC | Devices and methods for optical detection of nucleic acid hybridization |
6415725, | Apr 28 2000 | Janome Sewing Machine Co., Ltd. | Sewing machine with a work pressing bar positioning device |
6475809, | Jul 14 1998 | Zyomyx, Incorporated | Protein arrays for high-throughput screening |
6493097, | Aug 04 1999 | GE Healthcare Bio-Sciences AB | Analytical method and apparatus |
6503760, | Mar 16 2000 | GE Healthcare Bio-Sciences AB | Method for capturing analytes eluted from surface-bound ligands |
6549011, | Dec 20 2000 | Radiodetection Limited | Conductor tracing system |
6589798, | Dec 12 1996 | GE Healthcare Bio-Sciences AB | Method and system for analyte determination |
6594011, | Jul 11 2000 | Maven Biotechnologies, LLC | Imaging apparatus and method |
6698454, | Nov 02 2000 | GE Healthcare Bio-Sciences AB | Valve integrally associated with microfluidic liquid transport assembly |
6710870, | |||
6714303, | Feb 04 1997 | GE Healthcare Bio-Sciences AB | Analytical method and apparatus |
6806051, | Sep 25 2000 | LABCYTE INC | Arrays of partially nonhybridizing oligonucleotides and preparation thereof using focused acoustic energy |
6810286, | Mar 06 2000 | Medtronic, Inc | Stimulation for delivery of molecular therapy |
6833920, | Jul 11 2000 | Maven Biotechnologies, LLC | Apparatus and method for imaging |
6859280, | Jul 11 2000 | Maven Biotechnologies, LLC | Imaging apparatus and method |
6882420, | Jul 11 2000 | Maven Biotechnologies, LLC | Apparatus and method for imaging |
6981526, | Dec 16 1998 | NKT Flexibles I/S | Armoured flexible pipe and use of same |
7045287, | Jul 20 1999 | Agilent Technologies, Inc | Method for contacting fluid components with moieties on a surface |
7193711, | Jul 11 2000 | Maven Biotechnologies, LLC | Imaging method and apparatus |
7195872, | Nov 09 2001 | 3DBIOSURFACES TECHNOLOGIES, LLC | High surface area substrates for microarrays and methods to make same |
7233391, | Nov 21 2003 | PerkinElmer LAS, Inc. | Optical device integrated with well |
20020019019, | |||
20020021443, | |||
20020154311, | |||
20020182717, | |||
20030022388, | |||
20030067612, | |||
20030112432, | |||
20030148401, | |||
20030175160, | |||
20030205681, | |||
20030232384, | |||
20040002167, | |||
20040012676, | |||
20040023247, | |||
20040030504, | |||
20040038268, | |||
20050105091, | |||
20050110989, | |||
20050148063, | |||
20070159629, | |||
20070178012, | |||
AU742417, | |||
D472644, | May 16 2001 | GE Healthcare Bio-Sciences AB | Chip carrier for biosensor apparatus |
D480149, | May 16 2001 | GE Healthcare Bio-Sciences AB | Cover for a measuring cassette for biosensor apparatus |
RE35716, | Aug 02 1988 | Gene Tec Corporation | Temperature control apparatus and method |
WO3056337, | |||
WO3102580, | |||
WO8911057, | |||
WO9100467, | |||
WO9608720, | |||
WO9638729, | |||
WO9719375, | |||
WO9832002, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
May 21 2008 | DULTZ, SHANE C | MAVE TECHNOLOGIES, LLC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 020988 | /0181 | |
May 21 2008 | RALIN, DAVID | MAVE TECHNOLOGIES, LLC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 020988 | /0181 | |
May 22 2008 | Maven Technologies, LLC | (assignment on the face of the patent) | / | |||
Feb 01 2013 | Maven Technologies, LLC | FINNE, RONALD | SECURITY AGREEMENT | 029922 | /0633 | |
Feb 01 2013 | Maven Technologies, LLC | SHAPIRO, HERB | SECURITY AGREEMENT | 029922 | /0633 | |
Feb 01 2013 | Maven Technologies, LLC | O HARA, MAUREEN | SECURITY AGREEMENT | 029922 | /0633 | |
Feb 01 2013 | Maven Technologies, LLC | SCHWARTZBARD, JANET | SECURITY AGREEMENT | 029922 | /0633 | |
Feb 01 2013 | Maven Technologies, LLC | SCHWARTZBARD, MICHAEL | SECURITY AGREEMENT | 029922 | /0633 | |
Feb 01 2013 | Maven Technologies, LLC | RASSMAN, SEAN | SECURITY AGREEMENT | 029922 | /0633 | |
Feb 01 2013 | Maven Technologies, LLC | RASSMAN, WILLIAM | SECURITY AGREEMENT | 029922 | /0633 | |
Oct 01 2013 | Maven Technologies, LLC | RASSMAN, WILLIAM RICHARD | SECURITY AGREEMENT | 031498 | /0530 | |
Feb 28 2014 | MAVEN TECHNOLOGIES, LLC, A NEVADA LIMITED LIABILILTY COMPANY DBA MAVEN BIOTECHNOLOGIES | STRATEC BIOTECHNOLOGIES USA, INC | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 032462 | /0029 | |
Aug 24 2016 | STRATEC BIOMEDICAL USA, INC | Maven Technologies LLC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 039808 | /0990 | |
Jan 23 2018 | FINNE, RONALD | Maven Technologies, LLC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 044854 | /0370 | |
Jan 23 2018 | SHAPIRO, HERB | Maven Technologies, LLC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 044854 | /0370 | |
Jan 23 2018 | O HARA, MAUREEN | Maven Technologies, LLC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 044854 | /0370 | |
Jan 23 2018 | SCHWARTZBARD, JANET | Maven Technologies, LLC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 044854 | /0370 | |
Jan 23 2018 | SCHWARTZBARD, MICHAEL | Maven Technologies, LLC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 044854 | /0370 | |
Jan 23 2018 | RASSMAN, SEAN | Maven Technologies, LLC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 044854 | /0370 | |
Jan 23 2018 | RASSMAN, WILLIAM | Maven Technologies, LLC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 044854 | /0370 | |
Feb 07 2018 | Maven Technologies, LLC | RASSMAN, WILLIAM | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 044855 | /0142 | |
Jul 12 2018 | RASSMAN, WILLIAM | Maven Biotechnologies, LLC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 046862 | /0501 |
Date | Maintenance Fee Events |
Apr 16 2015 | M2551: Payment of Maintenance Fee, 4th Yr, Small Entity. |
Apr 05 2019 | M2552: Payment of Maintenance Fee, 8th Yr, Small Entity. |
Jun 05 2023 | REM: Maintenance Fee Reminder Mailed. |
Oct 12 2023 | M2553: Payment of Maintenance Fee, 12th Yr, Small Entity. |
Oct 12 2023 | M2556: 11.5 yr surcharge- late pmt w/in 6 mo, Small Entity. |
Date | Maintenance Schedule |
Oct 18 2014 | 4 years fee payment window open |
Apr 18 2015 | 6 months grace period start (w surcharge) |
Oct 18 2015 | patent expiry (for year 4) |
Oct 18 2017 | 2 years to revive unintentionally abandoned end. (for year 4) |
Oct 18 2018 | 8 years fee payment window open |
Apr 18 2019 | 6 months grace period start (w surcharge) |
Oct 18 2019 | patent expiry (for year 8) |
Oct 18 2021 | 2 years to revive unintentionally abandoned end. (for year 8) |
Oct 18 2022 | 12 years fee payment window open |
Apr 18 2023 | 6 months grace period start (w surcharge) |
Oct 18 2023 | patent expiry (for year 12) |
Oct 18 2025 | 2 years to revive unintentionally abandoned end. (for year 12) |